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ABSTRACT
Objective To determine whether isolated patients 
admitted to hospital have a higher incidence of adverse 
events (AEs), to identify their nature, impact and 
preventability.
Design Prospective cohort study with isolated and non- 
isolated patients.
Setting One public university hospital in the Valencian 
Community (southeast Spain).
Participants We consecutively collected 400 patients, 
200 isolated and 200 non- isolated, age ≥18 years old, to 
match according to date of entry, admission department, 
sex, age (±5 years) and disease severity from April 2017 
to October 2018. Exclusion criteria: patients age <18 years 
old and/or reverse isolation patients.
Primary and secondary outcome measures The 
primary outcome as the AE, defined according to the 
National Study of Adverse Effects linked to Hospitalisation 
(Estudio Nacional Sobre los Efectos Adversos) criteria. 
Cumulative incidence rates and AE incidence density rates 
were calculated.
Results The incidence of isolated patients with AEs 16.5% 
(95% CI 11.4% to 21.6%) compared with 9.5% (95% CI 
5.4% to 13.6%) in non- isolated (p<0.03). The incidence 
density of patients with AEs among isolated patients was 
11.8 per 1000 days/patient (95% CI 7.8 to 15.9) compared 
with 4.3 per 1000 days/patient (95% CI 2.4 to 6.3) among 
non- isolated patients (p<0.001). The incidence of AEs among 
isolated patients was 18.5% compared with 11% for non- 
isolated patients (p<0.09). Among the 37 AEs detected in 33 
isolated patients, and the 22 AEs detected in 19 non- isolated 
patients, most corresponded to healthcare- associated 
infections (HAIs) for both isolated and non- isolated patients 
(48.6% vs 45.4%). There were significant differences with 
respect to the preventability of AEs, (67.6% among isolated 
patients compared with 52.6% among non- isolated patients).
Conclusions AEs were significantly higher in isolated 
patients compared with non- isolated patients, more than 
half being preventable and with HAIs as the primary cause. 
It is essential to improve training and the safety culture of 
healthcare professionals relating to the care provided to this 
type of patient.
INTRODUCTION
Isolation precautions are an effective and 
simple method to achieve improved patient 
safety and infection control, minimising 
the potential of microorganism cross- 
contamination in the hospital setting and 
reducing healthcare- associated infections 
(HAIs). However, the application of these 
precautions, as well as entailing an increase 
in the consumption of resources, may not be 
without risks.1 2
Isolation precautions for preventing 
contamination through contact, droplets or 
by airborne transmission involve the applica-
tion of specific patient- handling protocols. 
These include the use of physical barriers 
on healthcare staff, such as masks, gloves, 
gowns and eye protection and limits on 
patient visits.1 This scenario entails a series 
of attitudes and beliefs in healthcare staff 
that may affect the handling, care and safety 
of the isolated patient. Among the factors 
that can influence healthcare staff are fear 
of self- contamination, work overload due to 
the time involved in preparing adequately to 
Strengths and limitations of this study
 ► This is the first prospective cohort study to examine 
the incidence of adverse events (AEs) in isolated and 
non- isolated patients in our clinical setting.
 ► Our study also included patients in isolation because 
of colonisation with multidrug- resistant micro- 
organisms, and was not limited to patients with 
infections.
 ► The sample size included 400 patients, a larger 
sample size than previous studies.
 ► Those inherent to medical records, such as missing 
data and limited predetermined information includ-
ed in the AE Monitoring and Control (Sistema de 
Información para la Vigilancia y Control de Efectos 
Adversos" (SIVCEA)) System database.
 ► Potential misclassification error might also have oc-
curred based on wrong clinical judgements made by 
the reviewer of clinical records, although there was 
found to be good concordance between the review-
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care for this type of patient, and insecurity associated with 
scant specific training.2
Some studies suggest that isolation could be associated 
with patient safety incidents.3–8 These incidents include 
adverse events (AEs) and incidents that cause harm to the 
patient, as well as those incidents that, even though they 
may not have caused harm, could cause harm in other 
situations (incident without harm).9
A systematic review which included 16 studies on the 
impact of isolation policies on patient safety, psycholog-
ical well- being, satisfaction, as well as the time spent by 
professionals on patient care, showed a negative impact on 
psychological well- being, including higher rates of depres-
sion and anxiety in isolated patients compared with non- 
isolated patients.3 Furthermore, a higher number of errors 
from health professionals during the isolated patients’ 
healthcare were observed, including a higher proportion of 
days without nurses’ progress notes (14% vs 10%; p<0.001) 
or medical progress data (26% vs 13%; p<0.001). Moreover, 
when compared with non- isolated patients, those who were 
isolated had double the probability of suffering an AE for 
each 1000 days in hospital (31 vs 15; p<0.001), and eight 
times higher probability of experiencing falls, pressure 
ulcers or electrolyte imbalances.1
Thus, recommending ‘isolation’ for a patient may entail 
greater resource consumption along with a decrease in the 
frequency and healthcare quality for patients with higher 
incidences of HAI and levels of dissatisfaction with the 
healthcare provided.3 4 In fact, a recent systematic review 
and meta- analysis has shown that there were a number 
of apparently negative aspects to contact precautions, in 
particular with regard to psychological effects and a reduc-
tion in the quality of some aspects of care.10
The objective of this study was to determine whether 
there was a higher incidence of AEs in isolated patients 
compared with patients not subject to isolation who 
had been admitted to a public university hospital, and 






The target population were residents in the catchment 
area of Sant Joan d’Alacant Public University Hospital, 
which covers a population of 234 424 and has a total of 
390 beds in the region of Valencia (southeast Spain). This 
is a referral hospital which belongs to the National Health 
System (Sistema Nacional de Salud, SNS) and attends all 
individuals living in its catchment area. The majority of 
the population in Spain (98.5%) uses the SNS as their 
main medical service.
Participants
We prospectively collected data from consecutive isolated 
and non- isolated patient ≥18 years old admitted between 
April 2017 and October 2018.
Isolated patients were those submitted to infection 
control precautions based on transmission (contact, 
airborne or droplets) at some time during their hospital 
stay. Non- isolated patients were those who underwent 
standard precautions and were not subject to isolation 
during their hospital stay. Isolated patients and non- 
isolated patients were selected consecutively to match 
according to date of admission, department, sex, age (±5 
years) and severity, measured using the McCabe scale 
(used in the Estudio de Prevalencia de las Infecciones 
Nosocomiales en España (EPINE) study)11
Exclusion criteria
Patients <18 years old and/or reverse isolation patients.
Patients and public involvement
Neither patients nor the public were involved in the 
design, conduct, reporting or dissemination plans of our 
research. Data from patients participating in this study 
were collected from clinical records. Therefore, patients 
were not interviewed nor did they have any contact with 
any of the researchers of this study.
Sample size
According to the cohort study published by Stelfox et al,1 
the relative risk in isolated patients for any type of AE was 
2.2. Based on this data and accepting an alpha risk of 0.05 
and a beta risk of 0.2 in a bilateral contrast, at least 176 
subjects are required in the exposed group and 176 in the 
non- exposed group in order to detect a relative minimum 
risk of 2.2, the incidence in patients with an AE in the non- 
exposed group being 9.3%, taking the results of the Estudio 
Nacional Sobre los Efectos Adversos (ENEAS) study.12 
In our study, a total sample of 400 patients (200 isolated 
patients and 200 non- isolated patients) was selected.
Data collection
We used the Incident Screening Guidelines to identify 
possible AEs. These guidelines were validated by the IDEA 
(Identificación de Efectos Adversos) project and used in 
the ENEAS study.12–14 Finally, we used the modular review 
form (MRF1)10 to review patients’ clinical histories. When 
the patient was discharged, the MRF215 16 was used as a 
confirmatory questionnaire with which an exhaustive 
analysis of the AE and its associated circumstances was 
undertaken. The data were collected by the trained staff.
Variables
Exposure variable
Isolation precautions according to transmission mech-
anism with duration of at least 48 hours and based on 
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Outcome variable
AE defined according to the ENEAS criterion as any 
unforeseen or unexpected accident included in the 
clinical history that has caused injury and/or incapacity 
and/or prolongation of the hospital stay and/or exitus, 
which derives from the healthcare provided and not the 
patient’s base disease.
To determine whether the AE is due to healthcare, the 
reviewers scored them on a 6- point scale (1=no or little 
evidence that the AE was due to patient handling; 6=full 
evidence that the AE was due to patient handling). A 
score greater than or equal to 4 was required for it to be 
defined as an AE due to healthcare.
The preventability of each AE was determined by 
the reviewer by means of a 6- point scale (1=absence of 
evidence of the possibility of prevention; 6=full evidence 
of the possibility of prevention).
Other covariates
Age, sex, the patient’s baseline health status and length 
of hospital stay. We also collected the type of isolation 
(contact, droplets and airborne)13 the cause of isolation 
(carrier, colonisation, infection) and the presence or 
otherwise of a multi- resistant germ.
Extrinsic risk factors such as: urinary catheter, periph-
eral venous catheter, arterial catheter, peripherally 
inserted central catheter, central venous catheter, 
parenteral nutrition, enteral nutrition, percutaneous 
endoscopic gastrostomy, nasogastric tube, tracheotomy, 
mechanical ventilation, immunosuppressive therapy, 
infusion pump, haemodialysis, peritoneal dialysis, para-
centesis therapy, immobilisation, sedation and number of 
drugs as regular medication.
Intrinsic risk factors such as: coma, hepatic cirrhosis, 
coronary heart disease, renal insufficiency, drug addic-
tion, hypertension, diabetes, obesity, hypercholestero-
laemia, neoplasia, hypoalbuminaemia/malnutrition, 
immunodeficiency/AIDS, pressure ulcer, alcoholism, 
chronic lung disease, sensory impairments, ABVD depen-
dent, neutropenia, cardiac insufficiency, dementia, 
pregnancy, peripheral vascular disease, skin disorder, 
motor impairment (neurological or rheumatic), altered 
consciousness (stupor, confusion), urinary incontinence, 
faecal incontinence, active smoking, social problems, 
psychiatric disease in active phase.
Statistical analysis
The characteristics of the study population have been 
described by means of the use of absolute and relative 
frequencies (percentages) in the case of qualitative vari-
ables. The quantitative variables have been expressed by 
means of the mean and SD (variables that follow a normal 
distribution) or by means of the median and IQR (vari-
ables that do not follow a normal distribution).
Cumulative incidence rates and AE incidence density 
rates have been calculated, with their respective 95% CIs 
and the association between the result variables and the 
rest of the variables being studied was measured by means 
of a bivariate analysis.
Logistic regression was used to analyse the indepen-
dent variables relating to the development, or not, of an 
AE. This has allowed us to control the confusion effect, or 
the interaction of some variables. For all the tests used, a 
statistical significance for values of p<0.05 was established.
RESULTS
Table 1 shows the characteristics of the population 
studied. There were 400 patients, 200 isolated and 200 
non- isolated, selected prospectively and consecutively. Of 
these 400 patients, 209 were women (52.2%, 104 isolated 
and 105 non- isolated) and 191 were men (47.8%, 96 
isolated and 95 non- isolated). The median age for both 
groups (isolated and non- isolated) was 75. Statistically 
significant differences were not found in relation to the 
presence of extrinsic factors, or in the mean length of 
hospital stay of isolated compared with non- isolated 
patients. However, among isolated patients, 75.5% had 
three or more risk factors compared with 64.5% in non- 
isolated patients (p 0.02).
The median length of hospital stay for both groups 
was the same (9 days). The total mean isolation time was 
11.7 days, with a mean of 12.3 days for colonised patients 
and 11.3 days for infected patients (p=0.07). The most 
frequent type of isolation was contact isolation (198/200 
patients, 99%) of which 35.8% were colonised and 64.1% 
were infected. In 74 patients (37%), the type of isolation 
was droplet transmission of which 14.9% were colonised 
cases and 85.1% were infected cases, and in two cases 
(1%) the type of isolation was airborne transmission 
(data not shown in table 1).
Table 2 shows the AE frequency, the length of hospital 
stay in days and the AE incidence density in both isolated 
and non- isolated patients. There were 37 AEs detected in 
33 of the isolated patients, and 22 AEs in 19 of the non- 
isolated patients. The incidence of AEs among isolated 
patients was 18.5%. (95% CI 13.1% to 23.9%), compared 
with 11% (95% CI 6.7% to 15.3%) in non- isolated patients 
(p<0.09).
Among the 33 isolated patients with AE, over half 
(63.6%) were men with a mean age at admission of 
67.7 years, the majority (84.8%) presenting at least one 
intrinsic risk factor and more than half (60.6%) with at 
least three intrinsic risk factors at admission. All presented 
extrinsic risk factors. The median length of hospital stay 
was 22 days. Moreover, of the 33 isolated patients with AE, 
13 experienced an extension of their hospital stay as a 
result and 4 had a hospital readmission. Moreover, the 
incidence of patients with AEs among isolated patients 
was 16.5% (95% CI 11.4% to 21.6%) compared with 9.5% 
(95% CI 5.4% to 13.6%) among non- isolated patients 
(p=0.037).The incidence density of patients with AEs 
among isolated patients was 11.8 per 1000 days/patient 
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patient (95% CI 2.4 to 6.3) among non- isolated patients 
(p<0.001) (data not shown in table 2).
Table 3 shows the characteristics of patients with AEs and 
the impact of these in isolated and non- isolated patients. 
Among the 19 non- isolated patients with AEs, 63.1% 
were women with a mean age of 73.8 years, the majority 
(89.4%) presenting at least one intrinsic risk factor and 
more than two- thirds (68.4%) with at least three intrinsic 
risk factors at admission. All but one patient presented 
extrinsic risk factors. The median length of hospital 
stay was 13 days. Moreover, six patients experienced an 
extension of their hospital stay as a result, and five had a 
hospital readmission.
Table 4 shows the results of the logistic regression 
model which identified the factors associated with the 
occurrence of an AE. Isolation increased the odds of 
experiencing an AE by 74% (OR 1.74; 95% CI 0.92 to 
3.25), although this result was not statistically significant 
(p=0.09). The presence of extrinsic risk factors did signifi-
cantly increase the risk of an AE by a factor of almost 3, 
and for each hospital stay day the risk of an AE rose by 
1%. However, the presence of intrinsic risk factors had 
a statistically significant protective effect against risk of 
having an AE (OR 0.19; 95% CI 0.06 to 0.65).
Table 5 shows the nature, severity and preventability of 
AEs. With respect to the nature of the AEs, from among 
the 37 AEs detected in 33 isolated patients with AE, and 
the 22 AEs detected in 19 non- isolated patients with AE, 
the majority corresponded to infections related to hospital 
care (48.6% vs 45.4%), followed by complications in the 
care (29.7% vs 18.2%) and the effects of medication 
(10.8% vs 27.3%) in isolated and non- isolated patients, 
Table 1 Characteristics of the study population
Variable Isolated patient (N=200) Non- isolated patient (N=200) Total (N=400) P value
Sex
  Woman 104 (52%) 105 (52.5%) 209 (52.2%) 0.92*
  Man 96 (48%) 95 (47.5%) 191 (47.8%)
Age
  Mean (SD) 72.3 (15.2) 72.4 (14) 72.3 (14.6) 0.80†
  Median (IQR) 75.5 (19.7) 75 (18) 75 (18)
Intrinsic risk factors
  Absence 8 (4%) 13 (6.5%) 21 (5.2%) 0.26*
  Presence 192 (96%) 187 (93.5%) 379 (94.8%)
No Intrinsic risk factors
  0 8 (4%) 13 (6.5%) 21 (5.2%) 0.02*
  1 17 (8.5%) 25 (12.5%) 42 (10.5%)
  2 24 (12%) 33 (16.5%) 57 (14.2%)
  3 or more 151 (75.5%) 129 (64.5%) 280 (70%)
Extrinsic risk factors
  Absence 5 (2.5%) 9 (4.5%) 14 (3.5%) 0.28*
  Presence 195 (97.5%) 191 (95.5%) 386 (96.5%)
Length of hospital stay (days)
  Median (IQR) 9 (13) 9 (10) 9 (11) 0.37†
*2 test.
†Mann- Whitney U test.
IQR, interquartile range; SD, standart deviation.
Table 2 Adverse events (AEs) frequency, length of hospital stay and AE incidence density in isolated and non- isolated 
patients
Isolated patient Non- isolated patient Total P value
AEs 37 22 59 <0.09
Length of stay in days 2786 4368 7154
AE incidence density/1000 days- patient 13.3 5 8.2
95% CI 9.0 to 17.6 2.9 to 7.1 6.1 to 10.4
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respectively. Of the 37 AEs detected in isolated patients, 
48.65% were considered of minor severity, 43.24% of 
moderate severity, and 8.11% of serious severity. In non- 
isolated patients, of the 22 AE detected, 50% were consid-
ered minor, 40.91% moderate and 9.09% serious. As to 
the preventability of the AEs, from among the 37 AEs 
detected in isolated patients, 25 (67.5%) were considered 
preventable compared with the 22 AEs detected in non- 
isolated patients, of which 10 (52.6%) were considered 
preventable.
DISCUSSION
We observed a higher significant incidence of patients 
with AEs related to healthcare in isolated patients. These 
results are supported by the conclusions of the three 
Table 3 Characteristics of patients with adverse events (AEs) and the impact of these in isolated and non- isolated patients
Isolated patient with 
AE
Non- isolated patient 
with AE
Total patients with 
AE P value
Sex
  Woman 12 (36.3%) 12 (63.1%) 24 (46.1%) 0.06*
  Man 21 (63.6%) 7 (36.8%) 28 (53.8%)
Age
  Mean (SD) 67.7 (15.8) 73.8 (13.8) 69.9 (15.3) 0.19†
  Median (IQR) 66 (25) 79 (14) 71 (23.2)
Intrinsic risk factors
  Absence 5 (15.1%) 2 (10.5%) 7 (13.4%) 1.00*
  Presence 28 (84.8%) 17 (89.4%) 45 (86.4%)
No intrinsic risk factors
  0 5 (15.1%) 2 (10.5%) 7 (13.4%) 0.79*
  1 4 (12.1%) 1 (5.2%) 5 (9.6%)
  2 4 (12.1%) 3 (15.7%) 7 (13.4%)
  3 or more 20 (60.6%) 13 (68.4%) 33 (63.4%)
Extrinsic risk factors
  Absence 0 (0.0%) 1 (5.2%) 1 (1.9%) 0.36*
  Presence 33 (100%) 18 (94.7%) 51 (98%)
Length of hospital stay (days)
  Mean (SD) 37.4 (36.5) 20.9 (16.9) 31.4 (31.6) 0.08
  Median (IQR) 22 (37.5) 13 (21) 21 (22.7)
Part of stay due to the AE
  Unknown 2 (6.06%) 2 (10.5%) 4 (7.7%) 0.51*
  Stay not extended 14 (42.4%) 6 (31.5%) 20 (38.5%)
  Part of stay 13 (39.4%) 6 (31.5%) 19 (36.5%)
  Caused readmission 4 (12.1%) 5 (26.3%) 9 (17.3%)
Readmission associated with an AE
  Yes 4 (12.1%) 5 (26.3%) 9 (17.3%) 0.26‡
  No 29 (87.8%) 14 (73.6%) 43 (82.7%)
*χ2 test
†Mann- Whitney U test.
‡Student’s t- test.
AE, adverse events; IQR, interquartile range; SD, standard deviation.
Table 4 Results of the logistic regression model which 
identified the factors associated with the occurrence of an 
adverse event
Variables OR 95% CI P value








2.55 1.35 to 4.82 0.00
Stay (days) 1.01 1.00 to 1.01 0.04
Age (years) 1.00 0.97 to 1.02 0.82
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systematic reviews which have examined the relation 
between AE in isolated and non- isolated patients.3 4 10
In our study, care- related infections were the most 
frequent cause of AE in both groups. On the other hand, 
in isolated patients, the second most frequent source of 
AEs related to care complications such as falls, pressure 
ulcers or electrolyte impairments, followed by medication 
effects. Whereas in non- isolated patients, the second most 
frequent causes of AEs were medication effects, followed 
by care complications.
These results coincide with previous studies that show 
that isolated patients have an eight times higher prob-
ability of experiencing care complications than non- 
isolated patients.18 19 Moreover, studies that focus on 
contact isolation precautions have identified AEs asso-
ciated with care complications, including medication 
errors, nosocomial pneumonia, falls or pressure ulcers. 
These results may indicate that isolated precautions 
could have a negative impact on medical professionals’ 
attitude towards the healthcare of these patients, which 
may be influenced by fears and concerns at exposing 
themselves to a higher risk of contamination. They could 
also be due to care complications such as lack of surveil-
lance linked to the extra work required by the isolation 
precautions.
Other publication highlight that control of infections 
by multidrug- resistant micro- organisms requires that 
standard precautions are respected consistently and with 
all patients. The decision to indicate special isolation 
precautionary measures requires evaluating the potential 
excess risk linked to the isolation.20
However, other studies did not find differences in the 
incidence of AE in patients subjected to isolation precau-
tions compared with non- isolated patients.2 21
In a study in which patients subjected to isolation in 
intensive care units were compared with a previous non- 
isolated status no differences were found between the AE 
incidence and the isolation status.2 This could be due to 
small sample size, and to the fact that only the hospital 
time spent in intensive care was analysed, which may have 
led to an underestimate of the frequency of AEs occur-
ring after patients were transferred to standard hospital 
care, along with the possible loss of information relating 
to the retrospective review of cases.
Another study, this time examining the impact of 
contact precautions on falls, pressure ulcers and transmis-
sion of methicillin- resistant Staphylococcus aureus (MRSA) 
and vancomycin- resistant Enterococcus (VRE) in hospi-
talised patients,21 compared the patients colonised or 
infected with MRSA or VRE (where contact precautions 
were discontinued) with other medical- surgical patients. 
MRSA/VRE patients had higher rates of falls and pressure 
ulcers, and rates were not affected by removal of contact 
precautions, suggesting that other factors contribute to 
these complications.
In our study, the incidence of AEs was associated with 
longer stays in hospital and a greater number of extrinsic 
risk factors (such as urinary catheter, peripheral venous 
catheter, parenteral nutrition, nasogastric tube, immuno-
suppressive therapy and the number of drugs as regular 
medication); this coincides with results of a previous 
study.12 However, the presence of intrinsic factors (such 
as coma, hepatic cirrhosis, coronary heart disease, renal 
insufficiency, hypertension, diabetes, obesity, hypercholes-
terolaemia, neoplasia) showed a protective effect against 
the occurrence of AEs. However, previous studies13 14 22 
indicate greater AE risk in patients exhibiting higher risk 
factor levels, both intrinsic and extrinsic. We believe that, 
for our population, the fact that they had intrinsic factors 
entailed a higher level of monitoring of these patients. 
These results were unexpected and further studies will 
be necessary with higher sample sizes in order to demon-
strate whether such a link exists.
Strengths and limitations of this study
In the present study, several limitations might have arisen. 
Those inherent to medical records, such as missing data 
and limited predetermined information included in the 
AE Monitoring and Control (Sistema de Información para 
la Vigilancia y Control de Efectos Adversos" (SIVCEA)) 
System database.
Potential misclassification error might also have 
occurred based on wrong clinical judgements made by 
the reviewer of clinical records; however, we tried to 
minimise this risk by including trained professionals in 
the screening guidelines (MRF1) and the MRF2 modular 
form to collect the data of the present study. A previous 
pilot study was carried out to train reviewers on medical 
data collection using these guidelines. Selection error 
Table 5 Characteristics and impact of adverse events (AEs) 











  Care- related infections 48.6 45.4
  Complications in care 29.7 18.2
  Effects of medication 10.8 27.3
  Complications with a 
procedure
5.4 –
  Other 5.4 9.1
Severity
  Minor 48.6 50.0
  Moderate 43.2 40.9
  Serious 8.1 9.1
Preventability
  Yes 67.6 52.6
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could also have occurred as a result of the participants 
not having been randomly selected, that is, exposed 
patients were included through consecutive sampling; 
however, we selected non- exposed patients to match with 
isolated patients as closely as possible, according to the 
date of admission and reference department, sex, age (±5 
years) and disease severity measured using the McCabe 
scale. However, the participants were incorporated over a 
long period of time (a year and a half) and consecutively, 
hence if their hospitalisation and isolation had been 
linked to particular times of the year, this effect would 
have been minimised by the fact that this incorporation 
took place at all times of year. Additionally, generalising 
our results to other populations is beyond the scope of 
our study.
The present study has several strengths. It is a prospec-
tive study with trained reviewers and high- quality measure-
ments performed to collect AE from medical records.
Moreover, this is the first prospective cohort study to 
examine the relationship between the incidence of AEs in 
isolated and non- isolated patients in our clinical setting. 
Furthermore, our study also included patients in isolation 
because of colonisation with multidrug- resistant micro- 
organisms, and was not limited to patients with infections.
Eventually, the sample size included 400 patients, a 
larger sample size than previous studies, adequately 
powered to identify differences between isolated and 
non- isolated patients.
CONCLUSIONS
In this study, we observed a higher incidence of AEs in 
isolated patients compared with non- isolated patients, of 
which 67.6% were preventable in isolated patients against 
52.6% in non- isolated patients.
With the increasing problem of antibiotic- resistant 
bacteria, among others, the need for isolation precau-
tions will continue to increase as a method of reducing 
nosocomial transmission of multidrug- resistant organ-
isms. However, as we have observed in this study, the deci-
sion whether or not to prescribe isolation precautions in a 
patient implies a potential added risk associated with the 
isolation process itself. Moreover, the isolated patients, 
given the greater complexity of their care, require on the 
one hand a greater awareness of this complex medical 
situation from care professionals, and on the other 
hand continuous professional training in the use of 
both standard isolation precautions and special isolation 
precautions.
We should also provide information for patients about 
isolation, as this can represent an opportunity to help 
with their recovery through minimising the psychological 
impact of transmission- based precautions.
In light of the results shown in this study, we recom-
mend classifying the precaution recommendations based 
on the transmission mechanism—drop, contact and 
airborne transmission—as recommended by the CDC.20 
Our results can help to prioritise the prescription of 
transmission- based precautions on specific patients in 
acute hospital care.
Recent developments—such as the appearance of 
new rapidly spreading viruses like SARS- CoV-2 along-
side the ongoing increase in the incidence of multidrug- 
resistant bacteria requiring particular care in terms of 
avoiding transmission—render increasingly important 
the appropriate training of health workers in standard 
and advanced precautions, so that healthcare is as safe as 
possible both for patients and health professionals. Also 
of ever increasing relevance will be the need for appro-
priate management of the pertinence and duration of 
precautions relating to transmission in hospitals, while 
allowing efficient healthcare, in the context of available 
health resources.
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